~~<i id='CE58002CE4'><strike id='CE58002CE4'><tt id='CE58002CE4'><pre id='CE58002CE4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：fashion 2025-08-11 18:37:49 - browse：245

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Report: NIH

entertainment

knowledge

focus

hotspot

entertainment

hotspot

MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

WSS

Lab trade group sues FDA to halt regulation of lab

First Opinion Podcast: What happens when kids become caregivers?

Health insurers say they are turning to AI to cut costs, improve care

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

South Korea throws huge K

Police still searching for prisoner who escaped from NYC hospital

focus

focus

entertainment

Bright Health sells Medicare Advantage business to Molina

What will save rural psychiatry services? Higher Medicaid payments

What does generative AI mean for health care? We asked experts

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Supreme Court strikes down use of affirmative action

NIH trials fail to test meaningful long Covid therapies, experts say

Hepatitis C has a cure — but many Americans still lack access to it

How to use technology to prevent future drug shortages

Activists slam private health insurers over coverage restrictions

Man killed during FBI raid in connection with threats against Biden, other officials

knowledge

Report: NIH

Akili, maker of video game for ADHD, to be acquired for 34 million

South Korea throws huge K

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

focus

hotspot

entertainment

hotspot